Eli Lilly and Company News
Novartis Follows Eli Lilly with $1.4 Billion Gene Editing Pact
Precision BioSciences is developing gene editing tools with several potential advantages over CRISPR.
Cramer's Mad Money Recap 6/15: Powell Crushes it
Jim Cramer says the Fed action is great news for high-growth tech stocks, which should be among the first sectors to recover.
Cramer's Mad Money Recap 6/7: Target, Smucker, Eli Lilly
Jim Cramer says smart investing is as simple as buying growth stocks when interest rates begin to fall.
Stock Market Today - 6/6: Dow Ends Slightly Higher as Treasury Yields Top 3%; Amazon Gains After 20-for-1 Split
Solid jobs and manufacturing data are prompting bets on a so-called 'Goldilocks' outcome for U.S. stocks as the Fed looks to tame inflation without choking-off growth.
Eli Lilly Stock Gains On Impressive Data From Jardiance Diabetes Drug Trial
"These five-year results ... showing empagliflozin was associated with a decreased risk of hospitalization for heart failure and for death, are encouraging data for adults with type 2 diabetes," said co-lead investigator Dr. Elisabetta Patorno.
Robinhood Stock Surges, Then Halted, Amid Reports of FTX Takeover Interest
Sam Bankman-Fried's FTX is looking for a path to buy online brokerage group Robinhood, Bloomberg reported Monday.
General Electric Stock Gains As CEO Larry Culp Takes Over Aviation Division
"There is tremendous opportunity in aviation over the coming years, and the Board and I decided it is the right time for me to take on this expanded role," said GE CEO Larry Culp.
Feds Could Stop Trump SPAC Deal
An investigation by a federal grand jury could halt the proposed SPAC deal with Trump's social media company.
McDonald's Brings Back a Classic Menu Item (with a Catch)
You never know what the fast-food chain might bring back or create a new version of.